Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease.
about
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.Recent insights into the biological functions of liver fatty acid binding protein 1Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variantFibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs).Top-down and bottom-up identification of proteins by liquid extraction surface analysis mass spectrometry of healthy and diseased human liver tissue.Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine.Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride LevelsLoss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female micePhenotypic divergence in two lines of L-Fabp-/- mice reflects substrain differences and environmental modifiers.The hepatic lipidome: a gateway to understanding the pathogenesis of alcohol-induced fatty liverLiver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma.Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis.Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice.Perilipin 5 restores the formation of lipid droplets in activated hepatic stellate cells and inhibits their activation.Ablating both Fabp1 and Scp2/Scpx (TKO) Induces Hepatic Phospholipid and Cholesterol Accumulation in High Fat-fed Mice.Perilipin 5 and Liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells.Rosuvastatin limits the activation of hepatic stellate cells in diet-induced obese mice.Ameliorative effect of naringin in acetaminophen-induced hepatic and renal toxicity in laboratory rats: role of FXR and KIM-1.
P2860
Q27021577-0A0EF548-2C4A-470C-A62C-76D54A6EFB4DQ27692609-7BEFDE82-8677-4807-A418-D11CDFDF388FQ28268205-FEDC92C7-5094-4FAD-B695-5E0FC0008AD4Q33581953-EFDC9596-6209-42C6-937B-B07572A83BE9Q34309876-20233A3F-C398-450E-B131-C9D51D3F8B70Q34340718-9DC18CCA-7206-4B41-8386-860CCC64EC41Q35071134-51304FE5-946B-4731-B633-176516CA4AE4Q35800550-33A863DD-ED39-44D3-B951-EE1083ECF794Q35911451-85111630-9B93-4685-8836-F5F075AE2540Q36174516-77D25ED3-4586-4035-BD5C-228FF2CB3FC8Q36590606-EB91C057-E510-45FC-B0B1-DF4110A0E247Q37109719-CB7C9A12-A075-40E3-BCD4-D289DE67E3C8Q38802973-6413733A-C497-45FD-AB5A-8D268BD5679CQ39062048-BE916560-6D53-40D9-A616-837AE880F6F4Q46457925-341F07D4-32B6-45A6-B361-2E095D1A4E97Q46554879-E4FB39AE-AD32-463E-BE14-2AFDFC3B2211Q47200557-B72A2785-F82D-4545-8511-84258012A392Q47215914-6662EDF7-F7B3-4530-BF51-380962009013Q51479885-4052EFB9-2961-401C-B836-133A287E37D8Q52876599-3D05C8F7-B0A8-456F-B494-54761AE80749
P2860
Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Liver fatty acid binding prote ...... alcoholic fatty liver disease.
@en
type
label
Liver fatty acid binding prote ...... alcoholic fatty liver disease.
@en
prefLabel
Liver fatty acid binding prote ...... alcoholic fatty liver disease.
@en
P2093
P2860
P356
P1433
P1476
Liver fatty acid binding prote ...... alcoholic fatty liver disease.
@en
P2093
Anping Chen
Elizabeth M Brunt
Elizabeth P Newberry
Fong-Fu Hsu
Haowei Song
Nicholas O Davidson
Susan M Kennedy
Victoria Davis
Youcai Tang
P2860
P304
P356
10.1002/HEP.26318
P407
P577
2013-05-15T00:00:00Z